Document:

Document

Exhibit 10.1
FABRINET

EXECUTIVE CHANGE IN CONTROL AND SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION

1.Introduction. This Executive Change in Control and Severance Plan and Summary Plan Description (as may be amended from time to time, this “Plan”) has been adopted by Fabrinet as of August 16, 2021 (the “Effective Date”), in order to provide certain protections to eligible employees of Fabrinet and/or its affiliates in connection with an involuntary termination of such eligible employee’s employment under the circumstances described in this Plan, including in connection with a change in control of Fabrinet.  Certain capitalized terms used in the Plan are defined in Section 2 below.

The Plan is an “employee welfare benefit plan,” as defined in Section 3(1) of ERISA.  This document constitutes both the written instrument under which the Plan is maintained and the summary plan description for the Plan, as required by ERISA.

2.Definitions.  The following terms referred to in the Plan will have the following meanings:

(a)“Administrator”  means the Company, acting through the Board (as defined below), the Committee or another duly constituted committee of members of the Board, or any person to whom the Administrator has delegated any authority or responsibility with respect to the Plan pursuant to Section 10, but only to the extent of such delegation.

(b)“Board” means the Company’s Board of Directors.

(c)“Cause” means, with respect to a Participant, the occurrence of any of the following:  (i) the Participant’s commission of any felony or any crime involving moral turpitude; (ii) the Participant’s willful breach of the Participant’s duties to the Company or any of its affiliates, including without limitation, theft from the Company or any of its affiliates or failure to fully disclose the Participant’s personal pecuniary interest in a transaction involving the Company or any of its affiliates; and (iii) engaging in (A) willful misconduct, (B) willful or gross neglect, (C) fraud, (D) misappropriation, or (E) embezzlement, in each case whether in the performance of the Participant’s duties under a written employment agreement or offer of employment letter between the Employer and the Participant, or otherwise.

(d)“Change in Control” means the occurrence of any of the following events: 

(i)Change in Ownership of the Company.  A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the shares of the Company that, together with the shares held by such Person, constitutes more than fifty percent (50%) of the total voting power of the shares of the Company; provided, however, that for purposes of this subsection, the acquisition of additional shares by any one Person, who is considered to own more than fifty percent (50%) of the total voting power of the shares of the Company will not be considered a Change in Control.  Further, if the shareholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company’s voting shares immediately prior to the change in ownership, direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the shares of the Company or of the ultimate 

parent entity of the Company, such event will not be considered a Change in Control under this subsection (i).  For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or

(ii)Change in Effective Control of the Company.  A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purposes of this subsection (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or

(iii)Change in Ownership of a Substantial Portion of the Company’s Assets.  A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company’s assets: (A) a transfer to an entity that is controlled by the Company’s shareholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s shares, (2) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding shares of the Company, or (4) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3).  For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

For purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of shares, or similar business transaction with the Company.

Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.

Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (x) its sole purpose is to change the jurisdiction of the Company’s incorporation, or (y) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.

(e)“Change in Control Period” means the period beginning on the date three (3) months prior to a Change in Control and ending on (and inclusive of) the date that is the one (1) year anniversary of a Change in Control.

(f)“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

(g)“Code” means the Internal Revenue Code of 1986, as amended.  Reference to a specific section of the Code or regulation thereunder will include such section or regulation, and any valid regulation or official guidance promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing, or superseding such section or regulation.

(h)“Committee” means the Compensation Committee of the Board.

(i)“Company” means Fabrinet, an exempted company incorporated with limited liability under the laws of the Cayman Islands, and any successor as described in Section 9.

(j)“Disability” means the Participant becoming unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months.

(k)“Eligible Employee” means a Section 16 Officer who has been designated by the Administrator as being eligible to participate in the Plan.  An individual automatically will be deemed to cease being an Eligible Employee (and a Participant, as applicable), upon termination of his or her status as a Section 16 Officer, except that during the Change in Control Period following a Change in Control, any Section 16 Officer who was a Participant as of immediately prior to the Change in Control will continue as a Participant while he or she remains employed with the Company (or its successor entity or affiliates) without regard to his or her continued status as a Section 16 Officer upon or after the Change in Control.

(l)“Employer” means, with respect to a Participant, the Company or the parent or subsidiary of the Company that directly employs such employee.

(m)“ERISA” means the Employee Retirement Income Security Act of 1974, as amended.  Reference to a specific section of ERISA will include such section and any valid regulation or other applicable guidance that has been promulgated under such section and is in effect.

(n)“Good Reason” means, with respect to a Participant, the Participant’s termination of his or her employment with the Company within thirty (30) days following the end of the Company’s Cure Period (as defined below) as a result of the occurrence of any of the following without the Participant’s written consent: (i) a material diminution in the Participant’s authority, duties or responsibilities (including following any Change in Control), or (ii) a material breach by the Company or the Employer of a written employment agreement or offer of employment letter between the Employer and the Participant or the Plan; provided, however, that a Participant must provide written notice to the Board of the condition that could constitute a “Good Reason” event within sixty (60) days following the initial existence of such condition and such condition must not have been remedied by the Company within thirty (30) days (the “Cure Period”) of such written notice.

(o)“Participant” means an Eligible Employee who has timely and properly executed and delivered his or her Participation Agreement to the Administrator, as set forth therein.

(p)“Participation Agreement” means the individual agreement provided by the Administrator to a Section 16 Officer, designating such Section 16 Officer as an Eligible Employee under the Plan.  A form of Participation Agreement is attached hereto as Appendix A.

(q)“Qualifying Termination” means a termination of a Participant’s employment with the Company (or subsidiary of the Company, as applicable) either (i) by the Company without Cause and other than due to the Participant’s death or Disability, or (ii) by the Participant for Good Reason.

(r)“Section 16 Officer” means an individual employed with the Company or any of its subsidiaries who, with respect to the Company’s ordinary shares, is subject to Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

(s)“Section 409A” means Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time.

(t)“Severance Benefits” means the compensation and other benefits that a Participant will be provided in the circumstances described in Section 4, and as set forth in Section 4 and his or her Participation Agreement.

3.Eligibility for Severance Benefits.  An individual is eligible for Severance Benefits under the Plan, as described in Section 4, only if he or she is a Participant on the date he or she experiences a Qualifying Termination and otherwise satisfies the requirements of the Plan.

4.Severance Benefits.

(a)Qualifying Termination Outside of the Change in Control Period.  In the event of a Participant’s Qualifying Termination that occurs other than during the Change in Control Period, the Participant will receive the following payments and benefits from the Company, subject to the requirements of this Plan:

(i)Salary Severance.  A single, lump sum, cash payment equal to fifty percent (50%) of the Participant’s annual base salary in effect as of the date of the Qualifying Termination.

(ii)Earned but Unpaid Bonus.  A single, lump sum, cash payment equal to the Participant’s earned but unpaid bonus as of the date of the Qualifying Termination.

(iii)COBRA Severance.  A single, lump sum, taxable, cash payment equal to the product of (A) eighteen (18) months, multiplied by (B) the amount of monthly premium that the Participant otherwise would be required to pay for the Participant and any of the Participant’s eligible dependents (if applicable) for the first month of Company group health care coverage under COBRA, without regard to whether the Participant elects continued health coverage under COBRA for the Participant and any of the Participant’s eligible dependents.

(iv)Expat Severance.  To the extent the Participant is receiving tax equalization benefits under the Company’s expatriate policy on the 

date of the Qualifying Termination, continued tax equalization benefits in accordance with the Company’s (or any of its subsidiary’s, as applicable) expatriate policy as in effect from time to time for (A) the calendar year in which the Qualifying Termination occurs, and (B) the calendar year immediately following the calendar year in which the Qualifying Termination occurs (the “Expat Severance”).

(b)Qualifying Termination During the Change in Control Period.  In the event of a Qualifying Termination that occurs during the Change in Control Period, the Participant will be eligible to receive the following payments and benefits from the Company, subject to the requirements of the Plan:

(i)Salary Severance.  A single, lump sum, cash payment equal to one hundred percent (100%) of the Participant’s annual base salary in effect as of the date of the Qualifying Termination or, if greater, the Participant’s annual base salary in effect as of immediately prior to the Change in Control.

(ii)Earned but Unpaid Bonus.  A single, lump sum, cash payment equal to the Participant’s earned but unpaid bonus as of the date of the Qualifying Termination.

(iii)Bonus Severance.  A single, lump sum, cash payment equal to one hundred percent (100%) of the Participant’s target annual bonus opportunity, in effect as of the date of the Qualifying Termination or, if greater, the Participant’s target annual bonus opportunity in effect as of immediately prior to the Change in Control.

(iv)COBRA Severance.  A single, lump sum, taxable, cash payment equal to the product of (A) eighteen (18) months, multiplied by (B) the amount of monthly premium that the Participant otherwise would be required to pay for the Participant and any of the Participant’s eligible dependents (if applicable) for the first month of Company group health care coverage under COBRA, without regard to whether the Participant elects continued health coverage under COBRA for the Participant and any of the Participant’s eligible dependents.

(v)Vesting Acceleration of Time-based Equity Awards.  One hundred percent (100%) vesting acceleration of any Company equity awards covering Company ordinary shares held by the Participant that are subject to continued service-based vesting criteria, but not subject to the achievement of any performance-based or other similar vesting criteria (“Time-based Awards”) and that are outstanding and unvested as of the date of the Qualifying Termination.  For the avoidance of doubt, in the event of the Participant’s Qualifying Termination that occurs prior to a Change in Control, any then outstanding and unvested portion of the Participant’s Time‐based Awards that may become vested pursuant to the preceding sentence will remain outstanding (and unvested) until the earlier of (x) three (3) months following the Qualifying Termination, or (y) a Change in Control that occurs within three (3) months following the Qualifying Termination, solely so that any benefits due on a Qualifying Termination can be provided if the 

Qualifying Termination occurs during the Change in Control Period (provided that in no event will the Participant’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration).  If no Change in Control occurs within three (3) months following a Qualifying Termination, any unvested portion of the Participant’s Time‐based Awards automatically and permanently will be forfeited on the date three (3) months following the date of the Qualifying Termination without having vested.

(vi)Expat Severance.  The Expat Severance, payable in accordance with the Company’s expatriate policy as in effect from time to time.

(c)Termination Other Than a Qualifying Termination.  If the termination of a Participant’s employment does not constitute a Qualifying Termination, then the Participant will not be entitled to receive any severance or other benefits except for those, if any, as may then be established under the Company’s then existing severance and benefits plans or programs.

(d)Non-Duplication of Payment or Benefits.  For purposes of clarity, in the event of a Qualifying Termination that occurs during the period within three (3) months prior to a Change in Control, any severance payments and benefits to be provided to the Participant under Section 4(b) will be reduced by any amounts that already were provided to the Participant under Section 4(a).  Notwithstanding any provision of the Plan to the contrary, if the Participant is entitled to any cash severance, payment or reimbursement of continued health coverage premiums, vesting acceleration of any Time-based Awards, tax equalization benefits or expatriate benefits, by operation of applicable law or under a plan, policy, contract, or arrangement sponsored by or to which the Company is a party other than the Plan (“Other Benefits”), then the corresponding severance payments and benefits under the Plan will be reduced by the amount of Other Benefits paid or provided to the Participant.

(e)Death of Participant.  In the event of a Participant’s death before all payments or benefits the Participant is entitled to receive under the Plan have been provided, the unpaid amounts will be provided to the Participant’s designated beneficiary, if living, or otherwise to the Participant’s personal representative in accordance with the terms of the Plan.

5.Treatment of Performance-based Awards.  Unless provided otherwise in a Participant’s Participation Agreement, any Company equity awards covering Company ordinary shares held by a Participant that are subject to the achievement of any performance-based or other similar vesting criteria (“Performance-based Awards”) are excluded from the vesting acceleration set forth in Section 4 above and instead will be governed by the award agreement applicable to such Performance-based Award.  For the avoidance of doubt, a vesting requirement relating solely to a Participant’s continued employment or other service will not be considered performance-based vesting criteria.

6.Accrued Compensation.  On any termination of a Participant’s employment with the Company, the Participant will be entitled to receive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to the Participant under any Company-provided plans, policies, and arrangements.

7.Conditions to Receipt of Severance.

(a)Separation Agreement and Release of Claims.  A Participant’s receipt of any severance payments or benefits upon a Qualifying Termination under Section 4 is subject to the Participant signing and not revoking a separation agreement and release of claims with the Company (the “Release”), which the Company will provide to the Participant no later than five (5) business days following the date of the Qualifying Termination, and which must become effective and irrevocable no later than the sixtieth (60th) day following the date of the Qualifying Termination (the “Release Deadline Date”).  If the Release does not become effective and irrevocable by the Release Deadline Date, the Participant will forfeit any right to severance payments or benefits under Section 4.

(b)Payment Timing.  Any lump sum cash severance payments under Section 4 relating to salary severance, bonus severance, and COBRA severance will be provided to the Participant on the first regularly scheduled payroll date of the Company following the date the Release becomes effective and irrevocable, subject to any delay required by Section 7(c) below.  Any restricted stock units and/or similar full value awards that accelerate vesting under Section 4(b)(v) will be settled, subject to any delay required by Section 7(c) below (or the terms of the award agreement or other Company plan, policy, or arrangement governing the settlement timing of the award to the extent such terms specifically require any such delay in order to comply with the requirements of Section 409A, as applicable), (x) on a date no later than ten (10) days following the date the Release becomes effective and irrevocable, or (y) if later, in the event of a Qualifying Termination that occurs prior to a Change in Control, on a date no later than the date of completion of the Change in Control.  Any Expat Severance will be paid as soon as practicable following the Participant’s taxable year in which the compensation covered by the Expat Severance was paid, and in no event later than the end of the Participant’s taxable year following the Participant’s taxable year in which the Participant remits the taxes relating to such compensation.

(c)Section 409A.  The Company intends that all payments and benefits provided under the Plan or otherwise are exempt from, or comply with, the requirements of Section 409A so that none of the payments or benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities and ambiguous terms in the Plan will be interpreted in accordance with this intent.  No payments or benefits to be provided to the Participant, if any, under the Plan or otherwise, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the “Deferred Payments”) will be paid or otherwise provided until the Participant has a “separation from service” within the meaning of Section 409A.  To the extent required to be exempt from or comply with Section 409A, references to the termination of the Participant’s employment or similar phrases used in the Plan will mean the Participant’s “separation from service” within the meaning of Section 409A.  Subject to subsection (ii) of this Section below, any Severance Benefits that are considered Deferred Payments that would be made during the sixty (60) day period immediately following the Participant’s separation from service will be paid on the sixtieth (60th) day following the Participant’s separation from service, or with respect to any Severance Benefits under Section 4(b) that become payable in connection with a Qualifying Termination that occurs prior to a Change in Control, if later, as of the date of the Change in Control (or, if applicable, in accordance with 

the terms of the award agreement or other Company plan, policy, or arrangement governing the settlement timing of the award to the extent such terms specifically require any such timing in order to comply with the requirements of Section 409A, as applicable).

(i)Any payments or benefits paid or provided under the Plan that satisfy the requirements of the “short-term deferral” rule under Treasury Regulations Section 1.409A-1(b)(4), or that qualify as payments made as a result of an involuntary separation from service under Treasury Regulations Section 1.409A-1(b)(9)(iii) that is within the limit set forth thereunder, will not constitute Deferred Payments for purposes of this Section 7(c).

(ii)Notwithstanding anything to the contrary in the Plan, if a Participant is a “specified employee” within the meaning of Section 409A at the time of the Participant’s separation from service (other than due to death), then any payments or benefits that constitute Deferred Payments payable within the first six (6) months after the Participant’s separation from service instead will be payable on the date six (6) months and one (1) day after the Participant’s separation from service; provided that in the event of the Participant’s death within such six (6) month period, any payments delayed by this subsection (ii) will be paid to the Participant in a lump sum as soon as administratively practicable after the date of the Participant’s death.

(iii)The Company reserves the right to amend the Plan and any Participation Agreement as it considers necessary or advisable, in its sole discretion and without the consent of a Participant or any other individual or person, to comply with any provision required to avoid the imposition of the additional tax imposed under Section 409A or to otherwise avoid income recognition under Section 409A prior to the actual payment of any benefits or imposition of any additional tax.  Each payment, installment, and benefit payable under the Plan is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).  In no event will a Participant have any discretion to determine the Participant’s taxable year of payment of any Deferred Payments.  In no event will the Company have any responsibility, liability, or obligation to reimburse, indemnify, or hold harmless a Participant for any taxes, penalties and interest that may be imposed, or other costs that may be incurred, as a result of Section 409A or any state law equivalent thereof.

8.Limitation on Payments.

(a)Best Results.  If any payment or benefit that a Participant would receive from the Company or any other party whether in connection with the provisions in the Plan or otherwise (the “Payments”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payments will be either delivered in full, or delivered as to such lesser extent that would result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, 

state and local income taxes and the Excise Tax, results in the Participant’s receipt, on an after-tax basis, of the greatest amount of Payments, notwithstanding that all or some of the Payments may be subject to the Excise Tax.  If a reduction in Payments is made in accordance with the immediately preceding sentence, the reduction will occur, with respect to the Payments considered parachute payments within the meaning of Code Section 280G, in the following order: (A) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced); (B) cancellation of equity awards that were granted “contingent on a change in ownership or control” within the meaning of Code Section 280G in the reverse order of date of grant of the awards (that is, the most recently granted equity awards will be cancelled first); (C) reduction of the accelerated vesting of equity awards in the reverse order of date of grant of the awards (that is, the vesting of the most recently granted equity awards will be cancelled first); and (D) reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced).  In no event will a Participant have any discretion with respect to the ordering of Payment reductions.  The Participant will be solely responsible for the payment of all personal tax liability that is incurred as a result of the payments and benefits received under the Plan, and the Participant will not be reimbursed, indemnified, or held harmless by the Company for any of those payments of personal tax liability.  For purposes of clarity, with respect to any Participant who was granted any equity awards under the Company’s Amended and Restated 2010 Performance Incentive Plan (the “2010 Plan”), the terms of this Section 8 shall control over, and supersede in their entirety, the provisions of Section 7.4 of the 2010 Plan (which section is titled “Golden Parachute Limitation”).

(b)Determination of Excise Tax Liability.  Unless the Company and a Participant otherwise agree in writing, any determinations required under this Section 8 will be made in writing by a nationally recognized accounting or valuation firm (the “Firm”) selected by the Company, whose determinations will be conclusive and binding upon the Participant and the Company for all purposes.  For purposes of making the calculations required by this Section 8, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  The Company and the Participant will furnish to the Firm such information and documents as the Firm reasonably may request in order to make determinations under this Section 8.  The Company will bear the costs and make all payments for the Firm’s services in connection with any calculations contemplated by this Section 8.  The Company will have no liability to the Participant for the determinations of the Firm.

9.Successors.  The Plan will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives of the Participant upon a Participant’s death, and (b) any successor of the Company.  Any such successor of the Company will be deemed substituted for the Company under the terms of the Plan for all purposes.  For this purpose, “successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company.  None of the rights of a Participant to receive any form of compensation payable pursuant to the Plan may be assigned or transferred except by will or the laws of descent and distribution.  Any other 

attempted assignment, transfer, conveyance, or other disposition of the Participant’s right to compensation or other benefits will be null and void.

10.Administration.  The Company is the administrator of the Plan (within the meaning of section 3(16)(A) of ERISA).  The Plan will be administered and interpreted by the Administrator (in its sole discretion).  The Administrator is the “named fiduciary” of the Plan for purposes of ERISA.  Any decision made or other action taken by the Administrator (or its authorized delegates) with respect to the Plan, and any interpretation by the Administrator (or its authorized delegates) of any term or condition of the Plan, or any related document, will be conclusive and binding on all persons and be given the maximum possible deference allowed by law.  In accordance with Section 2(a), the Administrator (a) in its sole discretion and on such terms and conditions as it may provide, may delegate in writing to one or more officers of the Company all or any portion of its authority or responsibility with respect to the Plan, and (b) has the authority to act for the Company (in a non-fiduciary capacity) as to any matter pertaining to the Plan; provided, however, that any Plan amendment or termination or any other action that reasonably could be expected to increase materially the cost of the Plan must be approved by the Board.

11.Eligibility to Participate.  To the extent that the Administrator has delegated administrative authority or responsibility to one or more officers of the Company in accordance with Sections 2(a) and 10, each such officer will not be excluded from participating in the Plan if otherwise eligible, but he or she is not entitled to act upon or make determinations regarding any matters pertaining specifically to his or her own benefit or eligibility under the Plan. The Administrator will act upon and make determinations regarding any matters pertaining specifically to the benefit or eligibility of each such officer under the Plan.

12.Clawback.  The Administrator may specify in a Participation Agreement that a Participant’s rights, payments, and/or benefits with respect to the payment and benefits under this Plan will be subject to reduction, cancellation, forfeiture, and/or recoupment upon the occurrence of certain specified events, in addition to any other terms and conditions applicable thereto.  Any payments and benefits under this Plan will be subject to the Company’s clawback policy as may be established from time to time.  The Administrator may require a Participant to forfeit or return to, or reimburse, the Company (or any of its subsidiaries, as applicable) all or a portion of the payments and benefits under this Plan pursuant to the terms of such Company policy or as necessary or appropriate to comply with applicable laws.

13.Term.  The Plan will become effective upon the Effective Date and will terminate automatically upon the completion of all benefits (if any) under the terms of the Plan.

14.Amendment or Termination.  The Company, by action of the Administrator, reserves the right to amend or terminate the Plan at any time, without advance notice (except as otherwise provided below) to any Participant or other person or entity, and without regard to the effect of the amendment or termination on any Participant or such other person or entity.  Any amendment or termination of the Plan will be in writing.  Notwithstanding the foregoing, any amendment to the Plan that (a) causes an individual or group of individuals to cease to be a Participant, or (b) reduces or alters to the detriment of the Participant the Severance Benefits potentially payable to him or her (including, without limitation, imposing additional conditions or modifying the timing of payment), will not be effective unless it both is (i) approved by the Administrator and (ii) communicated to the affected individual(s) in writing at least ninety (90) days before the effective date of the 

amendment or termination and, once a Participant has incurred an Qualifying Termination, no amendment or termination of the Plan may, without that Participant’s written consent, reduce or alter to the detriment of the Participant, the Severance Benefits payable to him or her (except as set forth in Section 7(c)(iii)).  In addition, notwithstanding the preceding, upon or after a Change in Control, the Company may not, without a Participant’s written consent, amend or terminate the Plan in any way, nor take any other action under the Plan, which (i) prevents that Participant from becoming eligible for Severance Benefits, or (ii) reduces or alters to the detriment of the Participant the Severance Benefits payable, or potentially payable, to him or her (including, without limitation, imposing additional conditions).  Any action of the Administrator, on behalf of the Company, in amending or terminating the Plan will be taken solely in a non‐fiduciary capacity.  For the avoidance of doubt, in no event will this Section 14 limit the Company’s (or its subsidiary’s) authority or discretion to determine the terms of any new or other compensation or benefit plan, program or arrangement, including without limitation, amending, suspending or terminating the Company’s (or its subsidiary’s) tax equalization policy, or to determine whether an individual will be appointed, or remain, a Section 16 Officer.

15.Claims and Review Procedure.

(a)Claims Procedure.  Any employee or other person who believes he or she is entitled to any payment under the Plan (or his or her authorized representative) may submit a claim in writing to the Administrator within ninety (90) days following the earlier of (a) the date the claimant learned the amount of his or her benefits under the Plan, or (b) the date the claimant learned that he or she will not be entitled to any benefits under the Plan.  If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based.  The notice also will describe any additional information needed to support the claim and the Plan’s procedures for appealing the denial.  The denial notice will be provided within ninety (90) days after the claim is received.  If special circumstances require an extension of time (up to ninety (90) days), written notice of the extension will be given within the initial ninety (90) day period.  This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision on the claim.

(i)Disability Claims Procedure.  A claim for benefits under the Plan that involves a determination of Disability by the Administrator (a “Disability Claim”) will be subject to all of the general rules described in this subsection (a), except as they are expressly modified by this subsection (a)(i).  If a Disability Claim is denied (in full or in part), the denial notice will be provided within forty-five (45) days after the claim is received.  If matters beyond the control of the Administrator require additional time, two extensions of up to thirty (30) days each are available.  Written notice of each extension will be given before the end of the initial forty‐five (45) day period or first thirty (30) day extension period, as applicable.  If an extension is required due to the claimant’s failure to submit necessary information, the extension notice will describe the additional information required and state that the claimant will be afforded at least forty-five (45) days within which to provide the specified information.  In such case, the period for making the determination on the Disability Claim will be tolled from the date of 

the extension notice until the claimant responds to the request for additional information.

A Disability Claim denial notice will include any internal rule, guideline, protocol or similar criterion relied upon in making the denial or, alternatively, it will state that such criterion does not exist.  The denial notice also will include a discussion of the Administrator’s decision, including an explanation of the Administrator’s basis for disagreeing with or not following: (a) the views presented by the claimant of health care professionals treating the claimant and vocational professionals who evaluated the claimant, (b) the views of medical or vocational experts whose advice was obtained on behalf of the Plan in connection with the claimant’s denial without regard to whether the advice was relied upon in making the benefit determination, and (c) a disability determination regarding the claimant presented by the claimant made by the Social Security Administration.  The notice additionally will include a statement that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant to the Disability Claim.  The notice will be provided in a culturally and linguistically appropriate manner consistent with U.S. Department of Labor Regulation Section 2560.503-1(o).

(b)Appeal Procedure. If the claimant’s claim is denied, the claimant (or his or her authorized representative) may apply in writing to the Administrator for a review of the decision denying the claim.  Review must be requested within sixty (60) days following the date the claimant received the written notice of their claim denial or else the claimant loses the right to review.  The claimant (or representative) then has the right to review and obtain copies of all documents and other information relevant to the claim, upon request and at no charge, and to submit issues and comments in writing.  The Administrator will provide written notice of its decision on review within sixty (60) days after it receives a review request.  If additional time (up to sixty (60) days) is needed to review the request, the claimant (or representative) will be given written notice of the reason for the delay.  This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision.  If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based.  The notice also will include a statement that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant to the claim and a statement regarding the claimant’s right to bring an action under Section 502(a) of ERISA.

(i)Disability Appeal Procedure.  A Disability Claim will be subject to all of the general rules described in this subsection (b), except as they are expressly modified by this subsection (b)(i).  Review of a denied Disability Claim must be requested within one hundred eighty (180) days following the date the claimant received the written notice of the Disability Claim denial or else the claimant loses the right to review.  Any entity or individual appointed by the 

Administrator to review the Disability Claim will consider the appeal de novo, without deference to the initial benefit denial.  The review of a Disability Claim will not include any person who participated or was consulted in the initial benefit denial or who is the subordinate of a person who participated or was consulted in the initial benefit denial.

A decision on appeal with respect to a Disability Claim will be made no later than forty-five (45) days after receipt of the request.  If additional time (up to ninety (90) days) is needed due to special circumstances to review the request, the claimant (or representative) will be given written notice of the reason for the delay.  Before any denial on appeal may be issued, the claimant will be provided, free of charge, with any new or additional evidence considered, relied upon, or generated in connection with the Disability Claim, and before any denial on appeal based on a new or additional rationale may be issued, the claimant will be provided, free of charge, with such rationale.  Any evidence or rationale required to be provided pursuant to this subsection (d)(i), must be provided as soon as possible and sufficiently in advance of the date on which the denial notice is required to be provided in order to give the claimant a reasonable opportunity to respond prior to that date.

In deciding an appeal of a Disability Claim denial based in whole or in part on medical judgement, the Administrator will consult with a health care professional who has appropriate training and experience in the field of medicine involved in the medical judgement.  The Administrator will identify any medical or vocational expert whose advice was obtained on behalf of the Administrator in connection with the denial, without regard to whether the advice was relied upon in making the benefit determination.  A Disability Claim denial notice also will include any internal rule, guideline, protocol or similar criterion relied upon in making the denial or, alternatively, it will state that such criterion does not exist.  The statement regarding the claimant’s right to bring an action under Section 502(a) of ERISA also will describe the contractual limitations period described in this subsection (c) below that applies to the claimant’s right to bring such an action, including the calendar date on which the contractual limitations period expires.  The denial notice additionally will include a discussion of the Administrator’s decision, including an explanation of the Administrator’s basis for disagreeing with or not following: (a) the views presented by the claimant of health care professionals treating the claimant and vocational professionals who evaluated the claimant, (b) the views of medical or vocational experts whose advice was obtained on behalf of the Plan in connection with a claimant’s denial without regard to whether the advice was relied upon in making the benefit determination, and (c) a disability determination regarding the claimant presented by the claimant made by the Social Security Administration.  The notice will be provided in a culturally and linguistically appropriate manner consistent with Department of Labor Regulation Section 2560.503-1(o).

(ii)Deemed Exhaustion of Plan Procedure.  In the case of a Disability Claim, if the Plan fails to strictly adhere to all of the requirements of this Section 15 with respect to such claim, the claimant will be deemed to have exhausted the Plan’s claims and appeal procedures for purposes of subsection (c) below.  Notwithstanding the foregoing, the Plan’s claims and appeal procedures will not be deemed exhausted based on a de minimis violation that does not cause, and is not likely to cause, prejudice or harm to the claimant, provided, the violation (i) was for good cause or due to matters beyond the Program’s control, (ii) occurred in the context of an ongoing, good faith exchange of information between the Plan and the claimant, and (iii) was not part of a pattern or practice of Plan violations.  The claimant may request a written explanation of such violation from the Plan, and within ten (10) days of the claimant’s request, the Plan will provide such explanation, including a specific description of the bases, if any, for asserting that the violation should not cause the Plan’s claims and appeal procedures to be deemed exhausted.  If a court rejects the claimant’s request for immediate review on the basis of deemed exhaustion under this subsection (b)(ii), the Disability Claim will be considered a re-filed for review upon the Plan’s receipt of the court’s decision.  Within a reasonable time after the receipt of the court’s decision, the Plan will provide the claimant with notice of the resubmission.

(c)Limitation on Right to Bring Action; Venue.  No legal action may be brought with respect to any claim for Plan benefits unless and until the claims and appeal procedures under the Plan applicable to such claim have been exhausted.  Any legal action with respect to a claim, if available, must be brought (a) no later than one (1) year after the Administrator’s final decision denying the claim on appeal, regardless of any state or federal statutes establishing provisions relating to limitations on actions, and (b) in Santa Clara County, California.  All determinations made by the Administrator (and its authorized delegates) in connection with their review of any claim will be afforded the maximum possible deference permitted by law.

16.Miscellaneous Provisions.

(a)Attorneys’ Fees. The parties will each bear their own expenses, legal fees and other fees incurred in connection with this Plan.

(b)Source of Payments.  Any Severance Benefits will be paid in cash from the general funds of the Employer; no separate fund will be established under the Plan, and the Plan will have no assets.  No right of any person to receive any benefit under the Plan will be any greater than the right of any other general unsecured creditor of the Employer.

(c)No Guarantee of Tax Consequences.  Participants (or their beneficiaries) solely will be responsible for any and all taxes with respect to any Severance Benefits provided under the Plan.  Neither the Administrator, the Company nor any other Employer makes any guarantees regarding the tax treatment to any person of any Severance Benefits provided under the Plan.

(d)Inalienability.  In no event may any current or former employee of any Employer sell, transfer, anticipate, assign or otherwise dispose of any right or interest under the Plan.  At no time will any such right or interest be subject to the claims of creditors nor liable to attachment, execution or other legal process.

(e)No Enlargement of Employment Rights.  Neither the establishment or maintenance or amendment of the Plan, nor the making of any benefit payments hereunder, will be construed to confer upon any individual any right to continue to be an employee of the Company or any other Employer.  The Company and any other Employer expressly reserve the right to discharge any of their employees at any time and for any reason.  However, as described in the Plan, a Participant may be entitled to benefits under the Plan depending upon the circumstances of the termination of his or her employment.

(f)Indemnification.  The Company hereby agrees to indemnify and hold harmless the officers and employees of the Company, and the members of the Board, from all losses, claims, costs or other liabilities arising from their acts or omissions in connection with the administration, amendment or termination of the Plan, to the maximum extent permitted by applicable law.  This indemnity will cover all such liabilities, including judgments, settlements and costs of defense.  The Company will provide this indemnity from its own funds to the extent that insurance does not cover such liabilities.  This indemnity is in addition to and not in lieu of any other indemnity provided to such person by the Company.

(g)Headings.  All captions and section headings used in the Plan are for convenient reference only and do not form a part of the Plan.

(h)Applicable Law; Choice of Law.  The Plan will be construed, administered, and enforced in accordance with ERISA and, to the extent applicable, the laws of the State of California without regard to the conflicts of law rules that may result in the application of the laws of any jurisdiction other than California.

(i)Severability.  The invalidity or unenforceability of any provision or provisions of the Plan will not affect the validity or enforceability of any other provision of the Plan, which will remain in full force and effect.

(j)Withholding.  All payments and benefits under the Plan will be paid subject to any applicable tax or other required withholdings.  The Company is authorized to withhold from any payments or benefits all federal, state, local, and/or non-U.S. taxes required to be withheld from the payments or benefits and make any other required payroll deductions.  Neither the Company nor any of its subsidiaries or affiliates has any duty or obligation to design its compensation policies, including without limitation, this Plan, in a manner that minimizes any Participant’s tax liabilities arising from the Participant’s compensation.  Neither the Company nor any of its subsidiaries or affiliates will pay a Participant’s taxes arising from or relating to any payments or benefits under the Plan.

(k)Counterparts.  The Plan may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

17.Additional Information.

						
	Plan Name:	Fabrinet Executive Change in Control and Severance Plan and Summary Plan Description
	Name, Address and Phone Number of Plan Sponsor:	Fabrinet
c/o Intertrust Corporate Services
One Nexus Way, Camana Bay
Grand Cayman, KY1-9005
Cayman Islands
+66 2-524-9600
	Plan Sponsor’s Federal Employer Identification Number:	98-1228572
	Plan Number:	510
	Plan Year:	The Plan’s initial Plan Year begins on the Effective Date and ends on June 24, 2022; thereafter the Plan Year will be the Company’s fiscal year.
	Name, Address and Phone Number of Plan Administrator:	Fabrinet
c/o Fabrinet USA, Inc. Attention: Administrator of the Fabrinet Executive Change in Control and Severance Plan and Summary Plan Description 4900 Patrick Henry D
Santa Clara, CA 95054
(408) 748-0900
legal@fabrinet.com

	Agent for Service of Legal Process:	Fabrinet
c/o Intertrust Corporate Services
One Nexus Way, Camana Bay
Grand Cayman, KY1-9005
Cayman Islands

Service of process also may be made upon the Administrator.
	Type of Plan	Severance Plan/Employee Welfare Benefit Plan.
	Plan Costs	The cost of the Plan is paid by the Company.

18.Statement of ERISA Rights.

As a Participant, you are entitled to certain rights and protections under ERISA.

(a)You may examine (without charge) all Plan documents, including any amendments and copies of all documents filed with the U.S. Department of Labor.  These documents are available for your review in the Parent’s Human Resources Department.

(b)You may obtain copies of all Plan documents and other Plan information upon written request to the Administrator.  A reasonable charge may be made for such copies.

In addition to creating rights for Participants, ERISA imposes duties upon the people who are responsible for the operation of the Plan.  The people who operate the Plan (called “fiduciaries”) have a duty to do so prudently and in the interests of you and the other Participants.  No one, including the Company or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a benefit under the Plan or exercising your rights under ERISA.  If your claim for a payment or benefit under the Plan is denied, in whole or in part, you must receive a written explanation of the reason for the denial.  You have the right to have the denial of your claim reviewed.  (The claim review procedure is explained in Section 15.)

Under ERISA, there are steps you can take to enforce the above rights.  For example, if you request materials and do not receive them within thirty (30) days, you may file suit in a federal court. In such a case, the court may require the Administrator to provide the materials and to pay you up to $110 a day until you receive the materials, unless the materials were not sent due to reasons beyond the control of the Administrator.  If you have a claim which is denied or ignored, in whole or in part, you may file suit in a federal court.  If it should happen that you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a federal court.

In any case, the court will decide who will pay court costs and legal fees.  If you are successful, the court may order the person you have sued to pay these costs and fees.  If you lose, the court may order you to pay these costs and fees, for example, if it finds that your claim is frivolous.

If you have any questions regarding the Plan, please contact the Administrator.  If you have any questions about this statement or about your rights under ERISA, you may contact the nearest area office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory, or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W. Washington, D.C. 20210.  You also may obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.

*          *          *
IN WITNESS WHEREOF, Fabrinet has adopted the Plan effective as of the Effective Date.

FABRINET

By:                                                               
Title:                                                             

Appendix A

FABRINET 
EXECUTIVE CHANGE IN CONTROL AND SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION

Form of Participation Agreement
Fabrinet (the “Company”) is pleased to inform you, [NAME], that you have been selected to participate in the Fabrinet Executive Change in Control and Severance Plan and Summary Plan Description (the “Plan”).  A copy of the Plan has been delivered to you with this Participation Agreement.  Your participation in the Plan is subject to all of the terms and conditions of the Plan, including this Participation Agreement.  Any capitalized term used in this Participation Agreement that is not otherwise defined herein will have the meaning ascribed to such term in the Plan.

A.Execution of Participation Agreement.  In order to actually become a Participant with respect to the Plan, you must complete and sign this Participation Agreement and return it to [NAME] no later than [DATE].

B.Severance Benefits.  As described more fully in the Plan, you may become eligible for certain Severance Benefits under Section 4 of the Plan if your employment with the Company (or subsidiary of the Company, as applicable) terminates as a result of a Qualifying Termination, subject to the terms and conditions of the Plan and this Participation Agreement.

C.Performance‐based Awards.  In addition, the following terms will apply to your Specified PSU Awards (as defined below):

1.Base PSU Awards.  For purposes of this Participation Agreement, “Base PSU Award” means: (a) the “base” Performance-based Restricted Share Unit award granted to you on [DATE], under the Company’s 2020 Equity Incentive Plan (the “2020 EIP”) and applicable award agreement thereunder; and (b) the “base” Performance-based Restricted Share Unit award granted to you on [DATE], under the Company’s 2020 EIP and applicable award agreement thereunder.

2.Stretch PSU Awards.  For purposes of this Participation Agreement, “Stretch PSU Award” means: (a) the “stretch” Performance-based Restricted Share Unit award granted to you on [DATE], under the Company’s 2020 EIP and applicable award agreement thereunder; and (b) the “stretch” Performance-based Restricted Share Unit award granted to you on [DATE], under the 2020 EIP and applicable award agreement thereunder (each such Stretch PSU Award or Base PSU Award, individually, a “Specified PSU Award,” or collectively, the “Specified PSU Awards”).

3.Treatment Upon Change in Control.  In the event of a Change in Control, to the extent that the Change in Control occurs on or before the last day of the performance period during which any performance-based vesting criteria under (a) a Base PSU Award must be met, then such Base PSU Award’s performance-based vesting criteria will be deemed to have been met in full and one hundred percent (100%) of the shares subject to the Base PSU Award will be scheduled to vest subject to your remaining a Service Provider (as defined in the 2020 EIP) through the last day of the performance period applicable to such Base PSU Award as set forth in the award agreement governing the terms of the Base PSU Award; and (b) a 

Stretch PSU Award must be met, then such Stretch PSU Award automatically will be forfeited as of immediately before the completion of the Change in Control and will not be eligible for any vesting in connection with the Change in Control or any payment of shares or other consideration therefor.  For purposes of clarity, if the last day of the performance period under any Specified PSU Award occurs before the date of a Change in Control, the Board or Committee will determine and certify in writing the extent of the Company’s achievement of applicable performance under such award before the Change in Control, subject to your remaining a Service Provider through the date of such certification or as otherwise provided in Section 4 below.

4.Qualifying Termination During Change in Control Period.  In the event of your Qualifying Termination that occurs before a Change in Control, any then outstanding and unvested portion of any Specified PSU Award will remain outstanding (and unvested) until the earlier of (a) three (3) months following the Qualifying Termination, or (b) a Change in Control that occurs within three (3) months following the Qualifying Termination, solely so that any benefits due on a Qualifying Termination can be provided if the Qualifying Termination occurs during the Change in Control Period.  If no Change in Control occurs within three (3) months following such Qualifying Termination, any unvested portion of your Specified PSU Award automatically and permanently will be forfeited on the date three (3) months following the date of the Qualifying Termination without having vested.  For the avoidance of doubt, for purposes of any Qualifying Termination that occurs during the Change in Control Period but before the Change in Control (a “Pre‐CIC Qualifying Termination”), any portion of a Specified PSU Award, that (i) remains outstanding, and (ii) is subject to vesting based only on your remaining a Service Provider and otherwise has become eligible to vest based on the applicable performance-based criteria being deemed achieved or otherwise no longer applicable, pursuant to the terms of the applicable Specified PSU Award documents, as modified herein, in each case as of immediately before the completion of the Change in Control, will be considered a Time‐based Award and eligible for the treatment described in Section 4(b)(v) of the Plan.  For purposes of clarity, with respect to any Pre‐CIC Qualifying Termination, any Stretch PSU Award for which the last day of the applicable performance period occurs before a Change in Control but during the Change in Control Period will be considered a Time-based Award and eligible for the treatment described in Section 4(b)(v) of the Plan only to the extent that the applicable performance-based criteria was achieved during the applicable performance period.  Further, for purposes of clarity, with respect to any Pre‐CIC Qualifying Termination, any Stretch PSU Award for which the last day of the performance period does not occur before the date of the Change in Control will be treated as described in clause (b) of Section C.3 of this Participation Agreement.  Accordingly, with respect to any Pre‐CIC Qualifying Termination, any Stretch PSU Award, for which the last day of the applicable performance period is more than three (3) months following any Qualifying Termination that occurs before a Change in Control, automatically and permanently will be forfeited upon such Qualifying Termination without having vested.

5.Other Performance-based Awards.  Any Company equity awards covering Company ordinary shares that do not constitute Base PSU Awards, Stretch PSU Awards, or Time‐based Awards will be governed by the award agreement applicable to such equity award.

In order to receive any Severance Benefits for which you otherwise become eligible under the Plan, you must sign and deliver to the Administrator the Release, which must become effective and irrevocable within the requisite period set forth in the Release and is subject to the Release timing requirements specified in the Plan.  Also, as explained in the Plan, your Severance Benefits (if any) generally may be subject to reduction if doing so would result, on an after-tax basis for you, in a greater amount of payments received or retained by you than if such payments were paid out in full and were subject to the “golden parachute” excise taxes under the Internal Revenue Code.

Please note that any Severance Benefits will be subject to any applicable U.S. federal, state, local and non-U.S. tax withholdings and any other required payroll deductions.

By your signature below, you and the Company agree that your participation in the Plan is governed by this Participation Agreement and the provisions of the Plan. Your signature below confirms that: (1) you have received a copy of the Fabrinet Executive Change in Control and Severance Plan and Summary Plan Description; (2) you have carefully read this Participation Agreement and the Plan, including, but not limited to, the terms and conditions of participation in, and receipt of any Severance Benefits, under the Plan; and (3) the decisions and determinations by the Administrator under the Plan will be final and binding on you and your successors, and will be given the maximum possible deference permitted by law.

FABRINET                                                               PARTICIPANT

                                                                                                                                
Signature                                                                     Signature

                                                                                                                                
Name                                                                           Date

                                                    
Title

Attachment: Fabrinet Executive Change in Control and Severance Plan and Summary Plan DescriptionExhibit 10.11

  

  

  

  
    
      CONSULTING AGREEMENT

      

      

      Quantum-Si Incorporated

      530 Old Whitfield St

      Guilford CT 06437

      

      

      August 12, 2021

      

      

      Dear Dr. Michael Mina:

      

      

      We are pleased that you (“Consultant”) have agreed to perform consulting services for Quantum-Si Incorporated (the “Company”).  This letter is to confirm our understanding with respect to (i)
        Consultant rendering services to the Company, (ii) your agreement to protect and preserve information and property that is confidential and proprietary to the Company or other parties with whom the Company is affiliated or does business, including,
        but not limited to, 4Catalyzer Corporation (“4C”) and each of the other companies that has received or currently receives services from 4C (the terms and conditions agreed to in this letter shall hereinafter be referred to as the “Agreement”).  The
        companies that currently receive services from 4C are AI Therapeutics, Inc., Hyperfine Research, Inc., Protein Evolution, Inc., Detect, Inc., and Tesseract Health, Inc. (such companies herein collectively the “Supported Companies”).  In
        consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:

      

      

      1.           Services of Consultant.

      

      

      (a)          Consultant agrees to render consulting services to the Company. The principal

      services will be as the Chief Medical Advisor (CMA) of the Company, and aiding in the specification, development and
          commercialization of therapeutic and diagnostic products and/or services relating to the Company’s business. From time to time Consultant and Company shall agree in writing (via email shall be sufficient) on
          the requirements and scope of each project, including any deliverables to be provided, and maximum hours billable for each such project.  Each project shall be completed and all deliverables delivered within the agreed number of hours (any
          additional hours required shall be performed without additional charge). All materials and documents produced in connection with Consultant’s services, and all versions thereof, shall be kept in a shared folder maintained by Company.  Company
          shall provide Consultant with access to such folder for such purpose. In performing consulting services for the Company, Consultant shall provide consultation at such times and locations as are mutually agreeable to the Company and Consultant. 
          To the extent that Consultant has employees and/or agents that shall perform services on its behalf in connection with this Agreement, Consultant shall ensure that all such employees and agents adhere to the terms of this Agreement (as though
          each such employee or agent constitutes “Consultant” hereunder).  Consultant shall be responsible and liable for any and all breaches of this Agreement caused by such employees or agents.  In connection with Consultant’s performance of services,
          the Company shall have the right to publicize Consultant’s affiliation with the Company. Consultant shall use its best efforts in the performance of the services.

      

      

      (b)          Consultant acknowledges and agrees that it will be an independent contractor for all purposes including, but not limited to, payroll and tax purposes.  Consultant shall not represent
        itself (or any of its employees or agents) as an employee or officer of the Company.

      

      

      
        
          

      

      (c)          Consultant acknowledges and agrees that it currently is not a party to, and during the term of this Agreement it will not enter into, any other, agreement, arrangement, understanding
        or other relationship pursuant to which Consultant is obligated to render advice and services to a commercial entity in the Company’s “Field of Interest.”  The term “Field of Interest” with respect to the Company currently means in vitro biochemistry, including genomics/DNA sequencing, metabolomics, and proteomics.  The Company may modify
        the definition of its Field of Interest by written notice to Consultant based on the activities in which the Company is then engaged or in which the Company then proposes to be engaged.

      

      

      2.           Term of Consulting Arrangement.  The term of this Agreement shall commence on April 19, 2021 and shall continue until terminated by either party providing written notice
        thereof (the “Term”).  The right of the Company or Consultant to terminate this Agreement, to which Consultant hereby agrees, shall be effective as of the date of such notice or as expressly indicated in such notice.

      

      

      
        3.          Compensation for Services. The Company shall pay as the exclusive compensation
          for the services and agreements hereunder for $22,500 per month for 60% of full-time service (“FTE”) provided by Consultant, payable monthly. Additionally, the Company shall grant you a non-qualified option to purchase up to 450,000 shares of the
          Company’s common stock vesting monthly (2.778%) over three (3) years beginning on May 31, 2021; provided however that during any monthly period when Consultant’s commitment to the Corporation is less than 60% FTE, the cash paid and shares that
          vest that month will be reduced proportionately based on the reduction in FTE percentage relative to 60% FTE, and any shares that would have otherwise vested will be irrevocably forfeited back to the Corporation. The Company will reimburse
          reasonable out-of- pocket expenses incurred at the Company’s request from time to time.

      

      

      

      4.         Continuing Obligations.  Consultant’s obligations and the Company’s obligations under this Agreement other than the provisions of Section 1 shall not be affected: (i) by any
        termination of this consulting arrangement, including termination upon the Company’s initiative; nor (ii) by any change in the nature of the services provided; nor (iii) by any interruption in the consulting arrangement.

      

      

      
        5.         Prohibited Competition.

      

      

      

      (a)  Certain Acknowledgements and Agreements.

      

      

      (i)  Company and Consultant have discussed, and Consultant recognizes and acknowledges the competitive and proprietary nature of the Company’s business operations.

      

      

      (ii)  Consultant acknowledges and agrees that a business will be deemed competitive with the Company if such business performs any of the services or develops, manufactures or
        sells any of the products or services in the Company’s Field of Interest (hereinafter, “Competitive”).

      

      

      (iii)  Consultant further acknowledges and agrees that, during the course of performing services for the Company, the Company will furnish, disclose or make available to
        Consultant, and Consultant may develop, confidential and proprietary information related to the Company’s business.  Consultant also acknowledges that such confidential information has been developed and will be developed by or on behalf of the
        Company through the expenditure by the Company of substantial time, effort and money.

      

      

      
        
          

      

      (b)  Covenants Not to Compete.  Consultant shall not, without the prior written consent of the Company:

      

      

      (i)  during the Term and for a period of one (1) year after termination thereof, for itself or on behalf of any other person or entity, directly or indirectly, either as
        principal, agent, stockholder, employee, consultant, representative or in any other capacity, own, manage, operate or control, or be concerned, connected or employed by, or otherwise associate in any manner with, engage in or have a financial
        interest in any business which is Competitive with the business of the Company within the United States of America (the “Restricted Territory”), except that nothing contained herein shall preclude Consultant from purchasing or owning securities of
        any such business if such securities are publicly traded, and provided that any holdings do not exceed three (3%) percent of the issued and outstanding securities of any class of securities of such business; or

      

      

      (ii)  during the Term and for a period of two (2) years after termination thereof, for itself or on behalf of or through any third party, service, solicit, divert or appropriate
        or attempt to service, solicit, divert or appropriate, for the purpose of engaging in a business Competitive with the business of the Company or any present or future parent, subsidiary or other affiliate of the Company which is engaged in a
        similar business as the Company, any customers or patrons of the Company, or any prospective customers or patrons with respect to which the Company has developed or made a sales presentation (or similar offering of services), located within the
        Restricted Territory; or

      

      

      (iii)  during the Term and for a period of two (2) years after termination thereof, for itself or on behalf of or through any third party, directly or indirectly, solicit, entice
        or persuade or attempt to solicit, entice or persuade any employees of or consultants to the Company or any present or future parent, subsidiary or affiliate of the Company to leave the services of the Company or any such parent, subsidiary or
        affiliate for any reason or to directly or indirectly hire, employ or retain or offer to hire, employ or retain on behalf of any business Competitive with the business of the Company any employee of or consultants to the Company or any present or
        future parent, subsidiary or affiliate of the Company.

      

      

      (c)  Reasonableness of Restrictions.  Consultant recognizes and acknowledges that (i) the types of services which are prohibited by this Section 5 are narrow and reasonable in relation to
        the scope of Consultant’s services which represent its principal salable asset both to the Company and to other prospective purchasers of Consultant’s services, and (ii) the specific but broad geographical scope of the provisions of this Section 5
        is reasonable, legitimate and fair to Consultant in light of the Company’s need to market its services and sell its products in a large geographic area in order to have a sufficient customer base to make the Company’s business profitable and in
        light of the limited restrictions on the type of services prohibited herein compared to the types of services that Consultant provides.

      

      

      (d)  Survival of Acknowledgements and Agreements.  Consultant’s acknowledgements and agreements set forth in this Section 5 shall survive the expiration or termination of this Agreement and
        the termination, for any reason, of consulting services.

      

      

      
        
          

      

      6.           Protected Information.  Consultant shall at all times, both during the Term and after any termination of this Agreement, maintain in confidence and shall not, without the prior
        written consent of the Company, use, except in the course of performing consulting services for the Company, disclose or give to others any fact or information which was disclosed to or developed by Consultant during the course of performing
        services for, or receiving training from, the Company, (or any customer, vendor, or third party in connection with your services to Company, including, but not limited to, 4C and the Supported Companies), and is not generally available to the
        public including, but not limited to, this Agreement, the terms hereof, the fact that Company is working with or has had discussions with you, technical data, trade secrets, know-how, show-how, research, product plans, products, services, customer
        lists and customers, markets, software, developments, Inventions (as defined in paragraph 3), processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or any other scientific,
        technical, trade or business information of the Company (or any customer, vendor, or third party in connection with your services to Company, including, but not limited to, 4C and the Supported Companies) developed by you or disclosed to you by the
        Company either directly or indirectly in writing, orally or by drawings or observation (collectively, “Confidential Information”).  Confidential Information shall additionally include, without limitation, the nature and existence of the discussions
        and of any relationship between the parties. For the avoidance of doubt, and notwithstanding anything herein to the contrary, Consultant shall not use or disclose any Confidential Information (including, but not limited to, product information,
        plans, ideas, designs, features, functions or specifications) to, or on behalf of, any third party in connection with promotion, marketing, or solicitation of any product, service or business.  Consultant also agrees not to file patents, copyrights
        or trademark applications based on the Company’s technology, property or Confidential Information, nor seek to make improvements thereon, without the Company’s approval.  Consultant agrees not to make any copies of such Confidential Information of
        the Company (except when appropriate for the furtherance of the business of the Company or duly and specifically authorized to do so) and promptly upon request by the Company, whether during or after the period of the consulting arrangement, to
        return to the Company or otherwise dispose of as requested by the Company any and all documentary, machine-readable or other elements or evidence of such Confidential Information, and any copies that may be in Consultant’s possession or control. 
        In the event Consultant is questioned by anyone not employed by the Company or by an employee of or a consultant to the Company not authorized to receive such information, in regard to any such information or any other secret or confidential work
        of the Company, or concerning any fact or circumstance relating thereto, Consultant will promptly notify the President of the Company.

      

      

      Consultant shall label all documents that contain Company’s confidential and/or proprietary information as follows (with no additional confidentiality or intellectual property notices):

      

      

      Quantum-Si Confidential & Proprietary

      Copyright © [year] Quantum-Si Incorporated

      

      

      
        7.         Ownership of Ideas, Copyrights and Patents.

      

      

      

      (a)  Property of the Company.  All ideas, discoveries, creations, manuscripts and properties, innovations, improvements, know-how, show-how, inventions (whether patentable or not), designs,
        trade secrets, developments, apparatus, techniques, methods, software, source and object code, technology, biological processes, cell lines, laboratory notebooks and formulas in or related to the Field of Interest, whether or not reduced to
        practice and whether or not patentable or copyrightable, which were or may be conceived, reduced to practice or developed during the Term or any other time during which Consultant is providing services to the Company or with the assistance of
        financial or other support from the Company (or if involving Confidential Information, conceived or developed during or after the Term) by Consultant, whether or not in conjunction with another or others, whether or not during business hours, and
        whether at the request or upon the suggestion of the Company or otherwise, (all of the foregoing, as well as any related improvements, modifications or derivatives thereof, being hereinafter referred to as the “Inventions”), shall be the sole and
        exclusive property of the Company.  To the maximum extent permitted by law, the Inventions referred to in the prior sentence will be deemed “works made for hire” as the term is used in the United States Copyright Act.  Consultant hereby assigns to
        the Company all worldwide right, title and interest in and to all of the Inventions, and all intellectual property rights therein, including the right to sue for and recover for past infringement.  All Inventions shall constitute the Confidential
        Information of the Company, subject to the protections set forth in Section 6 of this Agreement.  Consultant represents and warrants that it will conduct all services for or relating to the Company using its and/or Company’s equipment and resources
        (and no equipment or resource of any kind owned by any other person or business), such that any Inventions developed in connection with Consultant services to the Company shall be owned exclusively by the Company.  Consultant agrees to maintain and
        furnish to the Company complete and current records of all such Inventions and to disclose to the Company in writing all such Inventions.  Promptly after Company’s request, Consultant shall provide to the Company in writing a full, signed statement
        of all Inventions in which Consultant has participated.

      

      

      
        
          

      

      (b)  Cooperation.  At any time during or after the Term, Consultant agrees that it will fully cooperate with the Company its attorneys and agents, and the Company will compensate Consultant
        for time, effort and work in this regard during or after the Term as agreed to in Section 3 of this Agreement or as otherwise agreed by the Parties, in the preparation and filing of all papers and other documents as may be required to perfect the
        Company’s rights in and to any of such Inventions, including, but not limited to, promptly providing any facts or documents requested by Company pertaining to the Inventions, and joining in any proceeding to obtain letters patent, copyrights,
        trademarks or other legal rights of the United States and of any and all other countries on such Inventions, provided that the Company will bear the expense of such proceedings, and that any patent or other legal right so issued to Consultant shall
        be assigned by Consultant to the Company without charge.  Consultant hereby designates the Company as its agent, and grants to the Company a power of attorney with full power of substitution (which power of attorney shall be deemed coupled with an
        interest), for the purpose of effecting the foregoing assignments to the Company.

      

      

      8.         Disclosure to Third Parties.  Consultant agrees that Company may provide in its discretion, a copy of the covenants contained in Sections 1c, 5, 6 and 7 of this Agreement to any
        business or enterprise which Consultant may directly, or indirectly, own, manage, operate, finance, join, control or in which Consultant participates in the ownership, management, operation, financing or control, or with which Consultant may be
        connected as an officer, director, employee, partner, principal, agent, representative, consultant or otherwise.

      

      

      9.         Records.  Promptly after Company’s request, Consultant shall deliver to the Company or otherwise dispose of as requested by the Company any property of the Company which may be
        in Consultant’s possession including, but not limited to, all products, materials, memoranda, notes, keys, laboratory notebooks, records, data, reports, or documents, or copies of any of the foregoing.

      

      

      10.        No Conflicting Agreements.  Consultant hereby represents and warrants that it has no commitments or obligations inconsistent with this Agreement.  Consultant hereby agrees to
        indemnify and hold the Company harmless against any loss, damage, liability or expense arising from any claim based upon circumstances alleged to be inconsistent with such representation and warranty.  During the term of this Agreement, Consultant
        will not enter into any agreement, either written or oral, which may conflict with this Agreement, and Consultant will arrange to provide services under this Agreement in such a manner and at such times that such services will not conflict with
        Consultant’s obligations under any other agreement, arrangement, understanding, or relationship that Consultant may have with any third party.

      

      

      
        
          

      

      11.         Independent Contractors.  This Agreement does not constitute, and shall not be construed as constituting, an undertaking by the Company to hire Consultant (or any employee or
        agent thereof) as an employee of the Company.  Consultant acknowledges that it will be working as an independent contractor only.  Consultant will not be entitled to receive any of the benefits provided by the Company to its employees, and
        Consultant will be solely responsible for the payment of all federal, state and local taxes and contributions imposed or required on income, unemployment insurance, social security and any other law or regulation.

      

      

      12.         General.

      

      

      (a)  Notices.  All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party’s address set forth below or to such other
        address as a party may designate by notice hereunder, and shall be either (i) delivered by hand, (ii) sent by electronic internet mail, email, with a reply acknowledgement by recipient, (iii) sent by overnight courier, or (iv) sent by registered
        mail, return receipt requested, postage prepaid:

      

      

      	

            	If to the Company:	
              Quantum-Si Incorporated

            

      530 Old Whitfield St

      Guilford CT 06437

      Attn: Legal Dept.

      

      

      	

            	If to Consultant:	
              At the address set forth on the last page of this Agreement.

            

      

      

      All notices, requests, consents and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of such party set
        forth above, (ii) if made by email, at the time that receipt thereof has been acknowledged by electronic confirmation or otherwise, (iii) if sent by overnight courier, on the next business day following the day such notice is delivered to the
        courier service, or (iv) if sent by registered mail, on the fifth business day following the day such mailing is made.

      

      

      (b)  Entire Agreement.  This Agreement embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or
        written agreements and understandings relating to the subject matter hereof.  No statement, representation, warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or
        restrict, the express terms and provisions of this Agreement.

      

      

      (c)  Modifications and Amendments.  The terms and provisions of this Agreement may be modified or amended only by written agreement executed by the parties hereto.

      

      

      (d)  Waivers and Consents.  The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled
        to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.  Each such waiver or
        consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

      

      

      
        
          

      

      (e)  Assignment.  The Company may assign its rights and obligations hereunder to any person or entity who succeeds to all or substantially all of the Company’s business or that aspect of
        the Company’s business in which Consultant is principally involved.  Consultant’s rights and obligations under this Agreement may not be assigned without the prior written consent of the Company.

      

      

      (f)  Benefit.  All statements, representations, warranties, covenants and agreements in this Agreement shall be binding on the parties hereto and, in the case of the Company, its parents,
        subsidiaries and other affiliates; and shall inure to the benefit of the respective successors and permitted assigns of each party hereto.  Nothing in this Agreement shall be construed to create any rights or obligations except among the parties
        hereto, and no person or entity shall be regarded as a third‐party beneficiary of this Agreement.

      

      

      (g)  Governing Law.  This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the law of the Connecticut, without giving
        effect to the conflict of law principles thereof or any other state.

      

      

      (h)  Dispute Resolution.

      

      

      (i)  Any controversy, dispute or claim arising out of, related to or in connection with this Agreement that is not resolvable in a reasonable amount of time by diligent negotiation of the Parties
        to this Agreement shall be submitted for resolution to the exclusive jurisdiction of the United States District Court for the District of Connecticut sitting in New Haven County, or if that court is unable to exercise jurisdiction for any reason,
        the Connecticut State Courts sitting in New Haven County.

      

      

      (ii)  Company and Consultant each hereby irrevocably consent to the service of process in any lawsuit brought under this Agreement by delivery by hand to a party’s address set forth in Section
        12(a) or by mailing copies thereof by certified mail, postage prepaid, to the party at its address set forth in Section 12(a).

      

      

      (iii)  Company and Consultant each hereby irrevocably consent to the exclusive jurisdiction of the United States District Court for the District of Connecticut and the Connecticut state courts
        sitting in New Haven County.  Accordingly, with respect to any such court action, the Company and Consultant each hereby:  (A) submit to the personal jurisdiction of these courts; (B) waive any other requirement (whether imposed by statute, rule of
        court, or otherwise) with respect to personal jurisdiction or service of process; and (C) waive any objection to jurisdiction based on improper venue, improper jurisdiction, inconvenient forum, violation of public policy or any other basis.

      

      

      (iv)  Consultant and the Company each hereby expressly acknowledge that any breach or threatened breach of any of the terms and/or conditions set forth in Section 3, 5, 6 or 7 of this Agreement
        will result in substantial, continuing and irreparable injury to the non-breaching party.  Therefore, in addition to any other relief to which the non-breaching party may be entitled, Consultant and the Company each hereby agree that the
        non-breaching party shall be entitled to temporary, preliminary and permanent injunctive or other equitable relief in the event of any breach or threatened breach of the terms of Section 3, 5, 6 or 7 of this Agreement, without the need to post any
        bond.

      

      

      
        
          

      

      (i)  Severability.  The parties intend this Agreement to be enforced as written.  However, (i) if any portion or provision of this Agreement shall to any extent be declared illegal or
        unenforceable by a duly authorized court having jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not
        be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law; and (ii) if any provision, or part thereof, is held to be unenforceable because of the duration of such
        provision or the geographic area covered thereby, the Company and Consultant agree that the court making such determination shall have the power to reduce the duration and/or geographic area of such provision, and/or to delete specific words and
        phrases (“blue-penciling”), and in its reduced or blue-penciled form such provision shall then be enforceable and shall be enforced.

      

      

      (j)  Headings and Captions.  The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall in no way modify, or affect the meaning
        or construction of any of the terms or provisions hereof.

      

      

      (k)  No Waiver of Rights, Powers and Remedies.  No failure or delay by a party hereto in exercising any right, power or remedy under this Agreement, and no course of dealing between the
        parties hereto, shall operate as a waiver of any such right, power or remedy of the party.  No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment or discontinuance of steps to
        enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder.  The election of any remedy by a party hereto shall not constitute a waiver
        of the right of such party to pursue other available remedies.  No notice to or demand on a party not expressly required under this Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand in
        similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

      

      

      [REMAINDER OF PAGE BLANK]

      

      

      
        
          

      

      (l)  Counterparts.  This Agreement may be executed in one or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all
        of which together shall constitute one and the same instrument.

      

      

      If the foregoing accurately sets forth our agreement, please so indicate by signing and returning to us the enclosed copy of this letter.

      

      

      	 	
              Very truly yours,

            	 
	 	
              Quantum-Si Incorporated

            	 
	 	 	 	 
	 	By:	
              /s/ Christian LaPointe

            	 
	 	 	 	 
	 	Name:	
              Christian LaPointe

            	 
	 	 	 	 
	 	Title:	
              General Counsel

            	 

      

      

      	
              Accepted and Agreed:

            	 
	 	 	 
	By:	
               /s/ Michael Mina

            	 
	 	 	 
	Name:	
               Dr. Michael Mina

            	 
	 	 	 
	Address:	
              

              

            	 
	 	 	 
	 	 	 

      

      

      
        
          

      

      2021 Addendum to Consulting Agreement (the “Agreement”) Between

      Quantum-Si (“Company”) And

      Dr. Michael Mina (“Consultant”)

      

      

      Company acknowledges that Consultant’s primary responsibilities are to President and Fellows of Harvard College (“Harvard”) and that Consultant is required to comply with
        Harvard policies, including Harvard’s Statement of Policy in Regard to Intellectual Property, as amended, restated and renamed on February 4, 2008, and amended on October 4, 2010 and December 12, 2013, and
        as may be further amended from time to time (collectively, “Harvard Policies”). Company further acknowledges that the Harvard Policies take priority over any obligations that Consultant may have to Company by reason of the Agreement.

       

      Company agrees that it will not request or require Consultant, in the performance of his or her services to the Company, to employ proprietary information of Harvard, to make
        use of Harvard’s time or resources, or to involve Harvard students, employees, post-doctoral fellows or any other Harvard personnel other than Consultant.

      

      

      Nothing in the Agreement shall be construed to restrict or hinder Consultant’s ability to conduct current or future research or teaching assignments with Harvard, to limit
        Consultant’s ability to publish work generated in the performance of Consultant’s research or teaching at Harvard, or to infringe on Consultant’s academic freedom.

      

      

      Company further acknowledges that Consultant, in his or her capacity as a consultant, is not an agent or representative of Harvard for any purpose and has no authority to act
        for or bind Harvard. Without limiting the foregoing, any obligations pertaining to any confidential or other information provided to Consultant by Company will apply only to Consultant and not Harvard.

       

      Company may not use the name of Harvard or any of it schools or other units, other than to identify Consultant’s employer, without prior written permission from Harvard.

      

      

      To the extent that there is a conflict between the terms of the Harvard Policies or this Addendum, on the one hand, and the terms of the Agreement, on the other, the terms of
        the Harvard Policies and this Addendum shall control. Without limiting the foregoing, Company specifically acknowledges that Consultant cannot assign or convey to or vest in Company any rights in any intellectual property whatsoever, whether or not
        patentable or copyrightable, that conflict with Harvard’s rights in or to such intellectual property under the Harvard Policies.

       

      
        	Company	
                 

              	Consultant
	
                 

              	
                 

              	
                 

              
	
                By: /s/ Christian LaPointe

                Name: Christian LaPointe

                Title: General Counsel

                Date:  August 12, 2021

              	
                 

              	
                By: /s/ Michael Mina

                Michael J. Mina, MD, PhD

                August 12, 2021

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]